ETF Components for EUDG - WisdomTree Europe Dividend Growth Fu


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
NVS D 0.37 4.91
UL D -0.05 3.24
DEO F -0.58 1.50
ABBV F 1.26 1.39
LOGI F 1.87 0.22

Recent News for WisdomTree Europe Dividend Growth Fu & its Holdings

Date Stock Title
Nov 21 DEO JOHNNIE WALKER RENEWS SUCCESSFUL LUNAR NEW YEAR PARTNERSHIP WITH VISIONARY ARTIST JAMES JEAN
Nov 21 DEO Diageo “to pause” Crown Royal distillery construction in Canada
Nov 21 UL Unilever silent amid talk private-equity sale of ice cream off table
Nov 20 LOGI Logitech slips even as UBS upgrades on 'balanced' risk-reward
Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
Nov 20 UL Unilever ends plans to sell ice cream business to private equity - FT
Nov 20 DEO DELEÓN Tequila Unveils Its New Campaign and Brand Platform, "Bold Spirits, Rise"
Nov 19 DEO Diageo: No Path For Market-Beating Returns
Nov 19 ABBV Where Will AbbVie Be in 5 Years?
Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19 DEO Casa Redondo eyes “more muscle” with M&A on back of Safari “party drink” purchase – CEO Daniel Redondo
Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
Nov 19 UL Ben & Jerry’s sues parent company Unilever for stifling its stance on Gaza
Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 19 ABBV RVPH: Year-End OLE Update
Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Nov 18 ABBV AbbVie snaps eight straight sessions of losses
Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Europe Dividend Growth Index. The index consists of dividend-paying common stocks of companies with growth characteristics that are traded principally on a stock exchange in one of the following countries: Germany, Switzerland, United Kingdom,ect. At least 80% of the fund's total assets will be invested in the component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. It is non-diversified.
Exchange Traded Fund ETF Index Fund Dividend Wisdomtree Investments
Back to the Main EUDG Page...